Amos Bentzur is leading the Medical and Healthcare system regulation practice at Shibolet, advising healthcare systems and industries (public and privately owned), HMOs, pharmaceutical companies, clinical trials, startups, manufacturing, importing, release to – market, distribution, deviations, recalls, etc., medical device & digital health companies and service providers, the logistic centers in the industry in Israel, supply chains, pharmacy chains and most of the medical cannabis “players”. Mr. Bentzur is well known for his strategic contribution to clients, finding the right ways to open new markets. Amos was the owner and founder of Amos Bentzur law firm which merged, in early 2022, with Shibolet Law firm.
Mr. Bentzur is considered a worldwide expert on GMP/GDP regulation in Israel and outside of Israel, serving a variety of prestigious clients ranging from individual entrepreneurs to large HMOs and local and international public companies.
Mr. Bentzur is an expert and strategic consultant for healthcare systems and institutions, pharmaceutical companies, regulation, medical equipment manufacturers and companies, distributors and pharmacies, food and perfumes. He advises on these issues to multinational companies and collaborations, investors in projects in Israel and abroad in medical centers and companies in these fields.
Mr. Bentzur’s vision is and always was that a law firm that specializes in healthcare systems and related industries, must combine legal analysis with practical business understanding, enabling it to drive its clients’ success while maintaining the highest level of personal service.
In particular, Mr. Bentzur has a unique and broad experience in all regulatory aspects and crisis management concerning the pharmaceutical, medical device & digital health industries, healthcare systems, Specifically, specializes in implementing and assuring compliance of healthcare organizations, pharmaceutical and medical cannabis companies with the requirements of the Israeli and international standards concerning manufacturing, importation, and distribution of medicinal products (such as the European cGMP and cGDP guidelines), including different aspects of medical-grade cannabis.
DID YOU KNOW
Mr. Bentzur is regularly invited to participate in meetings and discussions held in the Ministry of Health and the applicable Parliamentary (“Knesset”) committees and actively participate and influence the legislative process and regulations governing the healthcare systems and the pharmaceutical industry.
